Effect of low dose Atorvastatin Calcium combined with Amlodipine Besylate on elderly patients with hypertension
LU Xin1 ZHAO Guifeng2▲
1.Department of Cardiovascular Medicine, Rocket Army Characteristic Medical Center， Beijing 100088, China;
2.Department of Critical Medicine, Rocket Army Characteristic Medical Center, Beijing 100088, China
Abstract：Objective To investigate the effect of low dose Atorvastatin Calcium combined with Amlodipine Besylate on elderly patients with hypertension. Methods From January 2016 to June 2019, 180 elderly patients with hypertension admitted to Rocket Army Characteristic Medical Center were selected and they were divided into the control group (90 cases) and the combined treatment group (90 cases) according to the random number table method. The control group was given Amlodipine Besylate orally and the combined treatment group was given Amlodipine Besylate+Atorvastatin Calcium orally. The changes of blood pressure, blood lipid and inflammatory factors between the two groups were compared. Results The average systolic blood pressure, average diastolic blood pressure, total cholesterol, triglyceride, low-density lipoprotein cholesterol, apolipoprotein a, homocysteine, high-sensitivity C-reactive protein, angiotensin Ⅱ levels after one, three months of treatment in the combined treatment group were lower than those in the control group, while high-density lipoprotein cholesterol level was higher than that of the control group (all P < 0.01). Conclusion The effect of adding low dose Atorvastatin Calcium on reducing blood pressure, blood lipid and inflammatory factors in patients with hypertension is significantly better than that of simple antihypertensive drug therapy, and low dose Atorvastatin Calcium and antihypertensive drugs have synergistic antihypertensive effect.
[1] 李苏宁，陈柞，王增武，等.我国老年人高血压现状分析[J].中华高血压杂志，2019，27（2）：140-148．
[2] Bilal M，Haseeb A，Lashkerwala SS，et al. Knowledge Awareness and Self-Care Practices of Hypertension among Cardiac Hypertensive Patients [J]. Glob J Health Sci，2015，8（2）：9-19.
[3] 乔瑞省，封娜.不同剂量阿托伐他汀对老年高血压患者血压变异性的影响[J].宁夏医科大学学报，2017，39（2）：201-203.
[4] 王鸫霖.瑞舒伐他汀与辛伐他汀在高脂血症患者中疗效及安全性对比[J].中国循证心血管医学杂志，2016，8（1）：78-80.
[5] Yuan Y，Zhang YY，Zhang XX，et al. Deciphering the genetic and modular connections between coronary heart disease,idiopathic pulmonary arterial hypertension and pulmonary heart disease [J]. Mol Med Rep，2016，14（1）：661-670.
[6] 曹博策，李丽，李刚.二氢吡啶和非二氢吡啶类钙拮抗剂在冠状动脉性心脏病合并高血压中的应用[J].中华高血压杂志，2018，26（4）：301-303.
[7] 李园春，杨冬，张秀梅.不同降压药物治疗高血压的临床疗效[J].江苏医药，2018，44（2）：179-182.
[8] 吴吉顺，梁青云.苯磺酸氨氯地平联合阿托伐他汀钙治疗原发性高血压合并高脂血症的疗效观察[J].广西医学，2014，36（7）：978-979.
[9] Wu GH，Kong FZ，Dong XF，et al. Association between hyperhomocysteinemia and stroke with atherosclerosis and small artery occlusion depends on homocysteine metabolism-related vitamin levels in Chinese patients with normal renal function [J]. Metab Brain Dis，2017，32（3）：859-865.
[10] Grossman C，Levin M，Koren-Morag N，et al. Left ventricular hypertrophy predicts cardiovascular events in hypertensive patients with coronary artery calcifications [J]. Am J Hypertens，2017，31（3）：313-320.
[11] 王清传，张志敏，于鸿杰，等.糖尿病大鼠血管平滑肌细胞内质网应激因子GRP78和caspase12的表达及阿托伐他汀的干预作用[J].山西医科大学学报，2018，49（9）：1031-1036.
[12] 王婷婷，李雪芹.阿托伐他汀钙片联合氨氯地平对老年冠心病合并高血压患者血清炎性因子及心率变异性的影响研究[J].国际检验医学杂志，2018，39（17）：2182-2184.
[13] 章剑美.瑞舒伐他汀钙与阿托伐他汀钙治疗高脂血症合并高血压的疗效比较[J].临床医药文献电子杂志，2018，5（4）：150.
[14] Kim SH，Jo SH，Lee SC，et al. Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and atorvastatin in Patients With Hypertension and Hypercholesterolemia：A Randomized，Double-blind，Factorial，Multicenter Phase Ⅲ Study [J]. Clin Ther，2016，38（10）：2171-2184.
[15] Wang Q，Guo YZ，Zhang YT，et al. The Effects and Mechanism of atorvastatin on Pulmonary Hypertension Due to Left Heart Disease [J]. PLoS One，2016，11（7）：157-171.
[16] 王敏.氨氯地平联合阿托伐他汀钙治疗高血压合并冠心病的临床疗效[J].按摩与康复医学，2019，10（2）：30-31.
[17] 樊彩妮，赵海鹰，蒋玲，等.苯磺酸氨氯地平和氨氯地平阿托伐他汀钙片治疗轻中度原发性高血压合并颈动脉粥样硬化患者的疗效[J].中华高血压杂志，2016，24（7）：674－677.
[18] Zhang K，Zhai S，Li K，et al. Effect of Atorvastatin on lower extremity function of patients with hypertension and peripheral arterial disease [J]. Pak J Pharm Sci，2017，30（1）：325-327.
[19] Zhou MS，Tian R，Jaimes EA，et al. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension [J]. Am J Hypertens，2014，27（6）：873-880.
[20] 张志玲，张火兵，纪明，等.100例不同年龄组的儿童继发性高血压患者血浆肾素活性血管紧张素Ⅱ醛固酮水平分析[J].标记免疫分析与临床，2018，25（6）：772-782.
[21] 杨仁强，黄玲，马晓欣，等.NLRP3炎症小体介导血管紧张素Ⅱ诱导的人脐静脉血管内皮细胞炎症因子IL-1β的表达[J].南方医科大学学报，2016，36（6）：790-795.
[22] Balashenka N，Podpalov V. Individual atorvastatin doses titration to treatment of carotid plaques in patients with arterial hypertension Ⅰ-Ⅱdegree [J]. Atherosclerosis，2016，252：e187.
2020, Vol. 17 
京公网安备 11010502046598号